Ekso Bionics Holdings, Inc.
EKSO
$3.49
$0.010.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -58.44% | -10.14% | 5.01% | -10.38% | 5.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -58.44% | -10.14% | 5.01% | -10.38% | 5.25% |
| Cost of Revenue | -46.48% | -13.07% | -4.12% | -10.74% | -5.55% |
| Gross Profit | -68.94% | -7.43% | 14.56% | -10.06% | 16.99% |
| SG&A Expenses | 2.23% | 0.17% | -7.24% | -3.71% | -24.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.20% | -5.38% | -11.76% | -10.21% | -18.94% |
| Operating Income | -70.24% | -0.12% | 35.34% | 9.96% | 45.49% |
| Income Before Tax | -12.13% | 15.69% | -6.19% | 38.42% | 42.88% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.13% | 15.69% | -6.19% | 38.42% | 42.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.13% | 15.69% | -6.19% | 38.42% | 42.88% |
| EBIT | -70.24% | -0.12% | 35.34% | 9.96% | 45.49% |
| EBITDA | -85.66% | -1.12% | 39.28% | 10.97% | 49.74% |
| EPS Basic | 37.51% | 42.16% | 37.74% | 57.33% | 57.26% |
| Normalized Basic EPS | 37.50% | 43.98% | 37.74% | 57.34% | 57.26% |
| EPS Diluted | 37.51% | 42.16% | 38.80% | 57.33% | 57.26% |
| Normalized Diluted EPS | 37.50% | 43.98% | 37.74% | 57.34% | 57.26% |
| Average Basic Shares Outstanding | 79.42% | 45.78% | 70.56% | 44.32% | 33.65% |
| Average Diluted Shares Outstanding | 79.42% | 45.78% | 70.56% | 44.32% | 33.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |